Cargando…
Host factors determining the efficacy of hepatitis C treatment
Combination therapy with pegylated interferon and ribavirin is the standard of care (SOC) for the treatment of chronic hepatitis C (CHC). Treating CHC with SOC may show a sustained virological response (SVR) in approximately 50–70 % of genotype 1 CHC patients and an SVR in 70–90 % of genotype 2 CHC...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Japan
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3698435/ https://www.ncbi.nlm.nih.gov/pubmed/23104468 http://dx.doi.org/10.1007/s00535-012-0669-x |